Table 1 Comparative presentation of blood analysis results
Laboratory analysis (reference range) | Upon admission – day 0 | Suspicion of NMS – day 5 | Follow-up - day 7 | Follow-up - day 11 | Follow-up - day 12 |
|---|---|---|---|---|---|
Sodium (136.0-145.0 mmol/l) | 144.0 | 133.0 | 138.0 | 136.0 | 140.0 |
Chlorides (98.0-107.0 mmol/L) | 104.7 | 96.0 | 102.1 | 101.9 | 104.1 |
Creatinine (62–106 umol/l) | 58 | 70 | 57 | 53 | 56 |
Urea (1.7–8.3 mmol/l) | 2.8 | 4.0 | 3.5 | 3.5 | 3.9 |
Uric acid (143–416 µmol/L) | 524 | 435 | 468 | 403 | 373 |
Aspartate aminotransferase - AST (< 40 IU/L) | 19 | 84 | 111 | 39 | 32 |
Alanine aminotransferase - ALT (< 41 IU/L) | 15 | 36 | 50 | 46 | 41 |
Direct bilirubin (< 5 µmol/L | / | 5.7 | / | 2.3 | 1.4 |
Albumins (30–50 g/L) | / | 51 | / | 48 | 48 |
Creatine phosphokinase - CPK (20–200 IU/L) | / | 1662 | 1416 | 344 | 212 |
Total leukocyte count (4.0–9.0 × 10^9/L) | 5.9 | 9.5 | / | 7.4 | 7.8 |
Platelets (150–350 × 10^9/L) | 243 | 295 | / | 360 | 358 |
C-reactive protein - CRP (< 5 mg/L) | / | 10.52 | / | 1.47 | 1.14 |
Sedimentation (2–12 mm/h) | 14 | 4 | / | / | 4 |